Literature DB >> 8110748

The calmodulin-binding domain of caldesmon binds to calmodulin in an alpha-helical conformation.

M Zhang1, H J Vogel.   

Abstract

The binding of calcium-calmodulin (CaM) to caldesmon (CaD) contributes to the regulation of smooth muscle contraction. It has been reported that a 17-residue synthetic peptide encompassing the residues Gly651-Ser667 of smooth muscle CaD constitutes its CaM-binding domain [Zhan, Q., Wong, S. S., & Wang, C.L.A. (1991) J. Biol. Chem. 266, 21810-21814]. This peptide does not share sequence homology with the CaM-binding domains of other proteins, and in addition, the binding of CaM to CaD is known to be relatively weak. Here we have investigated the properties of this atypical CaM-binding domain by NMR and circular dichroism (CD) spectroscopy. Two dimensional NMR studies performed in aqueous TFE mixture (75%/25%) showed that the peptide has the capacity to adopt an amphiphilic alpha-helical conformation. TRNOESY experiments and CD spectroscopy were used to determine that the CaD peptide binds in an alpha-helical conformation to CaM. The addition of TFE or the binding of the CaD peptide to CaM induces an alpha-helical structure only for the central 10 amino acid residues of the peptide. Titrations of CaM with the CaD peptide were followed by proton NMR and show the formation of a 1:1 complex and that the binding is calcium-dependent. The chemical shifts of 13C-methyl groups of specifically labeled Met residues and of the 15N backbone amide groups of CaM undergo changes upon addition of the CaD peptide; these data suggest that both domains and the central helix of CaM are involved in the binding of the peptide.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8110748     DOI: 10.1021/bi00171a016

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Interaction of proteolytic fragments of calmodulin with caldesmon and calponin.

Authors:  M V Medvedeva; E A Kolobova; P Wang; N B Gusev
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

2.  The calponin regulatory region is intrinsically unstructured: novel insight into actin-calponin and calmodulin-calponin interfaces using NMR spectroscopy.

Authors:  Mark Pfuhl; Sameeh Al-Sarayreh; Mohammed El-Mezgueldi
Journal:  Biophys J       Date:  2011-04-06       Impact factor: 4.033

3.  Substitution of the methionine residues of calmodulin with the unnatural amino acid analogs ethionine and norleucine: biochemical and spectroscopic studies.

Authors:  T Yuan; H J Vogel
Journal:  Protein Sci       Date:  1999-01       Impact factor: 6.725

4.  Molecular mechanism of multispecific recognition of Calmodulin through conformational changes.

Authors:  Fei Liu; Xiakun Chu; H Peter Lu; Jin Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

5.  Multiple-sited interaction of caldesmon with Ca(2+)-calmodulin.

Authors:  P A Huber; M El-Mezgueldi; Z Grabarek; D A Slatter; B A Levine; S B Marston
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

Review 6.  Calmodulin's flexibility allows for promiscuity in its interactions with target proteins and peptides.

Authors:  Aaron P Yamniuk; Hans J Vogel
Journal:  Mol Biotechnol       Date:  2004-05       Impact factor: 2.695

7.  Protein engineering and NMR studies of calmodulin.

Authors:  H J Vogel; M Zhang
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

8.  Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.

Authors:  K S Satheeshkumar; R Jayakumar
Journal:  Biophys J       Date:  2003-07       Impact factor: 4.033

9.  Roles of the C-terminal residues of calmodulin in structure and function.

Authors:  Chihiro Kitagawa; Akiko Nakatomi; Dasol Hwang; Issey Osaka; Hiroki Fujimori; Hideya Kawasaki; Ryuichi Arakawa; Yota Murakami; Shinya Ohki
Journal:  Biophysics (Nagoya-shi)       Date:  2011-05-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.